Aardvark Therapeutics, Inc. (AARD) income statement
AARDNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.92−0.08 (-7.74%)
Close on Nov 20, 2026Market cap $20.19MP/E –Yield –
Aardvark Therapeutics, Inc. financial ratios
See a number that looks wrong?